Citation 80485

CHAN,SC: CHANG,YS: WANG,JP: CHEN,SC: KUO,SC:. (1998). THREE NEW FLAVONOIDS AND ANTIALLERGIC, ANTI-INFLAMMATORY CONSTITUENTS FROM THE HEARTWOOD OF DALBERGIA ODORIFERA.. 64(2)

Citation Details

Title	THREE NEW FLAVONOIDS AND ANTIALLERGIC, ANTI-INFLAMMATORY CONSTITUENTS FROM THE HEARTWOOD OF DALBERGIA ODORIFERA.
Authors	CHAN,SC: CHANG,YS: WANG,JP: CHEN,SC: KUO,SC:
Year	1998
Volume	64
Issue	2

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Dalbergia odorifera (FABACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	VOUCHER SPECIMEN REPORTED FORISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DALBERGIONE,4-METHOXY:	None
2	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIONE,4-METHOXY:	ACTIVE
3	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIONE,4-METHOXY:	WEAK ACTIVITY
4	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DALBERGIONE,4-METHOXY:	EQUIVOCAL
5	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	CEAROIN	None
6	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MEDICARPIN	None
7	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CEAROIN	ACTIVE
8	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CEAROIN	ACTIVE
9	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CEAROIN	INACTIVE
10	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	INACTIVE
11	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	INACTIVE
12	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MEDICARPIN	EQUIVOCAL
13	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FORMONONETIN	None
14	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SATIVANONE	None
15	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
16	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	INACTIVE
17	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FORMONONETIN	WEAK ACTIVITY
18	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SATIVANONE	INACTIVE
19	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SATIVANONE	INACTIVE
20	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SATIVANONE	INACTIVE
21	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	COUMESTAN,3-HYDROXY-9-METHOXY:	None
22	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MELIOTOCARPAN A	None
23	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTAN,3-HYDROXY-9-METHOXY:	INACTIVE
24	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTAN,3-HYDROXY-9-METHOXY:	INACTIVE
25	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	COUMESTAN,3-HYDROXY-9-METHOXY:	INACTIVE
26	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELIOTOCARPAN A	WEAK ACTIVITY
27	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELIOTOCARPAN A	INACTIVE
28	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELIOTOCARPAN A	EQUIVOCAL
29	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LIQUIRITIGENIN,ISO:	None
30	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	STEVEIN	None
31	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	INACTIVE
32	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	INACTIVE
33	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN,ISO:	ACTIVE
34	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEVEIN	INACTIVE
35	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEVEIN	INACTIVE
36	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	STEVEIN	INACTIVE
37	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	LIQUIRITIGENIN	None
38	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVANONE,ISO: 2'-3-7-TRIHYDROXY: 4'-METHOXY: 3(R):	None
39	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN	INACTIVE
40	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN	EQUIVOCAL
41	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LIQUIRITIGENIN	EQUIVOCAL
42	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,ISO: 2'-3-7-TRIHYDROXY: 4'-METHOXY: 3(R):	INACTIVE
43	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,ISO: 2'-3-7-TRIHYDROXY: 4'-METHOXY: 3(R):	INACTIVE
44	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,ISO: 2'-3-7-TRIHYDROXY: 4'-METHOXY: 3(R):	ACTIVE
45	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,ISO: 2'-3-7-TRIHYDROXY: 4'-METHOXY: 3(R):	INACTIVE
46	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FLAVANONE,3'-4'-7-TRIHYDROXY:	None
47	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BUTEIN	None
48	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,3'-4'-7-TRIHYDROXY:	INACTIVE
49	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,3'-4'-7-TRIHYDROXY:	EQUIVOCAL
50	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVANONE,3'-4'-7-TRIHYDROXY:	INACTIVE
51	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTEIN	INACTIVE
52	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTEIN	ACTIVE
53	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BUTEIN	ACTIVE
54	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MELANETTIN,3'-HYDROXY:	None
55	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	KOPARIN	None
56	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANETTIN,3'-HYDROXY:	INACTIVE
57	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANETTIN,3'-HYDROXY:	INACTIVE
58	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANETTIN,3'-HYDROXY:	ACTIVE
59	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KOPARIN	INACTIVE
60	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KOPARIN	INACTIVE
61	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KOPARIN	ACTIVE
62	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	BOWDICHIONE	None
63	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	FISETIN	None
64	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BOWDICHIONE	WEAK ACTIVITY
65	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BOWDICHIONE	WEAK ACTIVITY
66	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BOWDICHIONE	INACTIVE
67	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	INACTIVE
68	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	INACTIVE
69	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FISETIN	ACTIVE
70	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVONE,3-3'-4'-6-TETRAHYDROXY: 7-METHOXY:	None
71	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	MELANETTIN	None
72	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-6-TETRAHYDROXY: 7-METHOXY:	INACTIVE
73	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-6-TETRAHYDROXY: 7-METHOXY:	INACTIVE
74	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,3-3'-4'-6-TETRAHYDROXY: 7-METHOXY:	INACTIVE
75	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANETTIN	INACTIVE
76	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANETTIN	INACTIVE
77	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	MELANETTIN	ACTIVE
78	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	SULFURETIN	None
79	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DAIDZEIN,3-HYDROXY:	None
80	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFURETIN	INACTIVE
81	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFURETIN	INACTIVE
82	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	SULFURETIN	EQUIVOCAL
83	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN,3-HYDROXY:	INACTIVE
84	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN,3-HYDROXY:	INACTIVE
85	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DAIDZEIN,3-HYDROXY:	WEAK ACTIVITY
86	Not specified	UV SPECTRUM GIVEN FORMASS-SPECTRAL FRAGMENTATION REPORTEDPMR SPECTRUM REPORTEDCMR SPECTRUM REPORTEDINFRARED SPECTRUM REPORTED FORQUANTITATIVE DATAISOLATION OF A COMPOUND WITH NOVEL STRUCTURE	FLAVONE,ISO: 2'-7-DIHYDROXY-4'-5'-DIMETHOXY:	None
87	Not specified	IDENTIFICATION IN BY GC/MSQUANTITATIVE DATA	VIOLANONE,3'-O-METHYL:	None
88	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 2'-7-DIHYDROXY-4'-5'-DIMETHOXY:	INACTIVE
89	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 2'-7-DIHYDROXY-4'-5'-DIMETHOXY:	INACTIVE
90	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	FLAVONE,ISO: 2'-7-DIHYDROXY-4'-5'-DIMETHOXY:	WEAK ACTIVITY
91	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIOLANONE,3'-O-METHYL:	INACTIVE
92	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIOLANONE,3'-O-METHYL:	INACTIVE
93	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	VIOLANONE,3'-O-METHYL:	ACTIVE
94	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	XENOGNOSIN B	None
95	Not specified	ISOLATION AND IDENTIFICATION OFQUANTITATIVE DATA	DALBERGIN	None
96	HISTAMINE RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XENOGNOSIN B	INACTIVE
97	LYSOZYME RELEASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XENOGNOSIN B	EQUIVOCAL
98	SUPEROXIDE PRODUCTION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	XENOGNOSIN B	ACTIVE

Citation 80485

Citation Details

Summary

Organisms and Their Experiments (1)

Dalbergia odorifera (FABACEAE)

Show SPARQL Queries (1)

Query 1